Published: May 14, 2021 | Tags: AzurRx BioPharma, P-II, MS1819, PERT, Cystic Fibrosis, Severe, Exocrine Pancreatic Insufficiency
Published: May 14, 2021 | Tags: Goldfinch Bio, P-I, Clinical Trial, GFB-024, Severe Insulin Resistant Diabetic Nephropathy
Published: May 14, 2021 | Tags: Reistone, P-III, RSJ10333 Trial, SHR0302, Atopic Dermatitis
Published: May 14, 2021 | Tags: Heron Therapeutics, Zynrelef, HTX-011, US, FDA, Approval, Postoperative Pain
Novo Nordisk Reports Results of Semaglutide from P-IIIa STEP 1 Trial in Patients with Obesity
Published: May 14, 2021 | Tags: Novo Nordisk, Semaglutide, P-IIIa, STEP 1 Trial, Obesity
Published: May 14, 2021 | Tags: Biogen, Envisagenics, RNA Splicing Research, AI Technology, Central Nervous System Diseases
Dr Reddy’s Acquires an Exclusive License for Pregene’s PRG1801 in India
Published: May 13, 2021 | Tags: Dr. Reddy’s, Exclusive License, Pregene, PRG1801, India
Published: May 13, 2021 | Tags: Fulcrum Therapeutics, US FDA, Fast Track Designation, Losmapimod, Facioscapulohumeral Muscular Dystrophy
Published: May 13, 2021 | Tags: AstraZeneca, Amgen, Tezepelumab, P-III, NAVIGATOR Study, Severe Asthma, ATS2021
Published: May 13, 2021 | Tags: Antengene, IND, Approval, P- III, SIENDO Trial, Selinexor, Advanced, Recurrent Endometrial Cancer
Biogen Exercises its Option to Acquire TMS-007 for Acute Ischemic Stroke
Published: May 13, 2021 | Tags: Biogen, TMS, TMS-007, Acute Ischemic Stroke, Acquisition
Published: May 13, 2021 | Tags: Regeneron, Sanofi, Libtayo, cemiplimab, P-III, Trial, Cervical Cancer, ESMO2021
Published: May 12, 2021 | Tags: InflaRx, Vilobelimab, P- II, IXPLORE Study, Anti-Neutrophil Cytoplasmic Auto-Antibody, Vasculitis
Published: May 12, 2021 | Tags: Medtronic, SonarMed Airway Monitoring System, Airway Obstruction, Ventilation, Pediatric Patients
Published: May 12, 2021 | Tags: Nanobiotix, Lianbio, NBTXR3, Head & Neck Squamous Cell Carcinoma, China, Korea, Singapore, Thailand
Published: May 12, 2021 | Tags: Incyte, MorphoSys, P-III, frontMIND Study, Tafasitamab, Lenalidomide, DLBCL
Cellectis Collaborates with Sanofi for Alemtuzumab to be Utilized in CART-Cell Trials
Published: May 12, 2021 | Tags: Cellectis, Sanofi, Alemtuzumab, CART-Cell Trials
Published: May 12, 2021 | Tags: Autobahn, Global Rights, Astellas, ASP3652, Brain Targeting Chemistry Platform
Lilly Signs a ~$1.25B Research Collaboration with MiNA Therapeutics to Develop saRNA Therapies
Published: May 11, 2021 | Tags: Lilly, ~$1.25B, MiNA Therapeutics, saRNA Therapies
Published: May 11, 2021 | Tags: Biogen, Capsigen, Novel AAV Capsids, CNS, Neuromuscular Disorders
Allergan Aesthetics to Acquire Soliton and its Resonic Device for ~$550M
Published: May 11, 2021 | Tags: Allergan Aesthetics, Soliton, Resonic Device, ~$550M
AstraZeneca and Amgen Submit BLA to US FDA for Tezepelumab to Treat Severe Asthma
Published: May 11, 2021 | Tags: AstraZeneca, Amgen, BLA, US, FDA, Tezepelumab, Severe Asthma
Pfizer and BioNTech Receive the US FDA’s EMA for COVID-19 Vaccine in Adolescents
Published: May 11, 2021 | Tags: Pfizer, BioNTech, US, FDA, EMA, COVID-19 Vaccine, Adolescents
Published: May 11, 2021 | Tags: Bayer, Finerenone, P- III, FIGARO-DKD CV Outcomes Study, Chronic Kidney Disease, Type 2 Diabetes
Published: May 10, 2021 | Tags: Aurinia, Lupkynis, voclosporin, P-III, AURORA 1 Study, Active Lupus Nephritis, The Lancet
Published: May 10, 2021 | Tags: Pfizer, BioNTech, BLA, US, FDA, Approval, COVID-19 Vaccine
Walmart Health Signs an Agreement to Acquire MeMD for its Telehealth Services
Published: May 10, 2021 | Tags: Walmart Health, MeMD, Telehealth Services
Published: May 10, 2021 | Tags: Eli Lilly, Diabetes Technology Companies, Connected, Insulin Pen Solutions
BD to Spin Off its Diabetes Care Business into New Public Company
Published: May 10, 2021 | Tags: BD, Spin Off, Diabetes Care Business, New Public Company
Published: May 10, 2021 | Tags: GSK, Vir, EMA, VIR-7831, sotrovimab, COVID-19
Related Post: PharmaShots Weekly Snapshots (May 03 – 07, 2021)
The post PharmaShots Weekly Snapshots (May 10 – 14, 2021) first appeared on PharmaShots.